{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:21:07Z","timestamp":1781846467875,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.06.056","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T22:00:29Z","timestamp":1372716029000},"page":"1218-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"L.","family":"Barroso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"W.A.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.06.056_bib0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1042\/bj0910222","article-title":"Estimation of the molecular weights of proteins by Sephadex gel-filtration","volume":"91","author":"Andrews","year":"1944","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4269\/ajtmh.1988.39.343","article-title":"Invasive amebiasis in naturally infected new world and old world monkeys with and without clinical disease","volume":"39","author":"Beaver","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-4894(02)00113-3","article-title":"Sequence conservation of the Gal\/GalNAc lectin from clinical isolates","volume":"101","author":"Beck","year":"2002","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0020","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/IAI.64.4.1473-1476.1996","article-title":"Oral immunization with a recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity","volume":"64","author":"Beving","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4269\/ajtmh.1996.55.693","article-title":"Seroepidemiology of Entamoeba histolytica in a slum in Northeastern Brazil","volume":"55","author":"Braga","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4269\/ajtmh.1994.50.412","article-title":"Seroepidemiology of amebiasis in Mexico","volume":"50","author":"Caballero-Salcedo","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pep.2006.01.014","article-title":"Refolding, purification, and characterization of human and murine RegIII proteins expressed in Escherichia coli","volume":"48","author":"Cash","year":"2006","journal-title":"Prot Express Purif"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4269\/ajtmh.1985.34.283","article-title":"Entamoeba histolytica: early progressive pathology in the cecum of the gerbil (Meriones unguiculatus)","volume":"34","author":"Chadee","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0050","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.69.9.5892-5898.2001","article-title":"The 150kDa Gal\/GalNAc lectin co-receptor of Entamoeba histolytica is a member of a gene family containing multiple CXXC sequence motifs","volume":"69","author":"Cheng","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0055","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1550-7408.1993.tb04926.x","article-title":"A redescription of Entamoeba histolytica Schaudinn 1903 (emended Walker 1911) separating it from Entamoeba dispar (Brumpt 1925)","volume":"40","author":"Diamond","year":"1993","journal-title":"J Eukary Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0035-9203(78)90144-X","article-title":"A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba","volume":"72","author":"Diamond","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1086\/314610","article-title":"Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal\/GalNAc lectin","volume":"179","author":"Dodson","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"Freedman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0075","series-title":"Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin test for Human and Animal Parenteral Drugs, Biological Products, and Medical Devices","year":"1987"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0080","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/IAI.00487-09","article-title":"Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon","volume":"77","author":"Guo","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0085","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1086\/320740","article-title":"Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children","volume":"183","author":"Haque","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0090","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1110\/ps.0233703","article-title":"The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient","volume":"12","author":"Ho","year":"2003","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.vaccine.2003.09.003","article-title":"Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal\/GalNac lectin","volume":"22","author":"Houpt","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0100","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.4049\/jimmunol.169.8.4496","article-title":"The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells","volume":"169","author":"Houpt","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0105","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1128\/IAI.00725-07","article-title":"Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge","volume":"75","author":"Ivory","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/IAI.74.1.528-536.2006","article-title":"CpG-Oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils","volume":"74","author":"Ivory","year":"2006","journal-title":"Infect Immun"},{"issue":"May 13","key":"10.1016\/j.vaccine.2013.06.056_bib0115","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case\u2013control study","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0125","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1111\/j.1550-7408.1998.tb04518.x","article-title":"Molecular analysis of the Gal\/GalNAc adhesion of Entamoeba histolytica","volume":"45","author":"Mann","year":"1998","journal-title":"J Euk Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0130","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/IAI.61.5.1772-1778.1993","article-title":"Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesion map to the cysteine-rich extracellular domain of the 170-kilodalton subunit","volume":"61","author":"Mann","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0135","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1073\/pnas.88.8.3248","article-title":"Sequence of the cysteine-rich heavy subunit of the galactose lectin of Entamoeba histolytica","volume":"88","author":"Mann","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408369609101485","article-title":"Recent advances in amebiasis","volume":"33","author":"Petri","year":"1996","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0145","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI113198","article-title":"Isolation of the galactose-binding lectin which mediates the in vitro adherence of Entamoeba histolytica","volume":"80","author":"Petri","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0150","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/S0021-9258(19)81714-3","article-title":"Subunit structure of the galactose and N-acetyl-d-galactosamine inhibitable adherence lectin of Entamoeba histolytica","volume":"264","author":"Petri","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.micro.56.012302.160959","article-title":"The bittersweet interface of parasite and host; lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica","volume":"56","author":"Petri","year":"2002","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0160","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1128\/IAI.67.8.3836-3841.1999","article-title":"The cysteine-rich region of the Entamoeba histolytica adherence lectin (170-kilodalton subunit) is sufficient for high affinity Gal\/GalNAc-specific binding in vitro","volume":"67","author":"Pillai","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2958.1996.356885.x","article-title":"Physical mapping and expression of gene families encoding the N-acetyl-d-galactosamine adherence lectin of Entamoeba histolytica","volume":"19","author":"Ramakrishnan","year":"1996","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4269\/ajtmh.1989.41.40","article-title":"Amebiasis now","volume":"41","author":"Ravdin","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0175","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI110377","article-title":"Role of adherence of cytopathogenic mechanisms of Entamoeba histolytica Study with mammalian tissue culture cells and human erythrocytes","volume":"68","author":"Ravdin","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0264-410X(93)90024-R","article-title":"Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica","volume":"11","author":"Ravdin","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0185","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1128\/IAI.65.8.3118-3125.1997","volume":"65","author":"Ryan","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/infdis\/171.3.645","article-title":"A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess","volume":"171","author":"Soong","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0195","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.63.2.472-477.1995","article-title":"Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen","volume":"63","author":"Soong","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0200","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.10.4.637","article-title":"Progress towards development of a vaccine for amebiasis","volume":"10","author":"Stanley","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0205","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/IAI.66.2.462-468.1998","article-title":"Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin","volume":"66","author":"Sultan","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4269\/ajtmh.1975.24.34","article-title":"Electron microscope studies of experimental Entamoeba histolytica infection in the guinea pig","volume":"24","author":"Takeuchi","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0215","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1073\/pnas.88.5.1849","article-title":"Primary structure of the 170kDa surface lectin of pathogenic Entamoeba histolytica","volume":"88","author":"Tannich","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"January 17","key":"10.1016\/j.vaccine.2013.06.056_bib0220","article-title":"An improved manufacturing process for a recombinant polyprotein vaccine","author":"Vedvick","year":"2008","journal-title":"BioPharm Int"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0225","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1091\/mbc.9.8.2069","article-title":"Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains the \u03b22 integrin motif","volume":"9","author":"Vines","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.vaccine.2013.06.056_bib0230","first-page":"97","article-title":"WHO","volume":"72","author":"WHO: Amoebiasis","year":"1997","journal-title":"Week Epidemiol Record"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T23:59:22Z","timestamp":1645919962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13008487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X13008487"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}